S. 3134In Committee
Combating Counterfeit Pharmaceuticals Act of 2025
Combats counterfeit pharmaceuticals by targeting their financing and related financial activity
Plain-English overview
What this bill does
Combats counterfeit pharmaceuticals by targeting their financing and related financial activity
Key points
- Prohibit counterfeit drug financing
Current status
Where it stands
Status
In Committee
Latest action
2025-11-06 — Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Related context
Topics and policy areas
undefinedCrime and Law EnforcementInternational Affairs